Clinical Trial Update: Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine

View source ↗

Summary

A clinical trial investigating the fractalkine-receptor axis in endometrial cancer has completed. The document provides the status without reporting results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Endometrial Cancer | Status: COMPLETED